Skip to main content
Hofseth BioCare ASA logo

Hofseth BioCare ASA — Investor Relations & Filings

Ticker · HBC ISIN · NO0010598683 LEI · 5967007LIEEXZXGGEO44 OL Manufacturing
Open in API
Filings indexed 731 across all filing types
Latest filing 2026-04-14 Regulatory Filings
Country NO Norway
Listing OL HBC

About Hofseth BioCare ASA

https://hofsethbiocare.no/

Hofseth BioCare ASA is a biotechnology company that develops and manufactures high-value nutritional ingredients from fresh Norwegian salmon off-cuts. Using a proprietary and patent-protected enzymatic hydrolysis process, the company gently extracts bioactive components, ensuring the preservation of their nutritional value. Its core products include soluble proteins (peptides), full-spectrum salmon oil, and marine calcium/collagen. These ingredients are utilized in clinically-proven finished products for both human nutrition and pet health markets, reflecting a commitment to sustainability and the full utilization of marine resources.

Recent filings

Filing Released Lang Actions
Hofseth BioCare ASA: HBC publishes paradigm-changing clinical trial results of OmeGo full spectrum omegas
Regulatory Filings Classification · 0% confidence The document is a press‐style announcement of clinical trial results for a product (OmeGo). It does not present actual financial results, regulatory filings (like a 10‐K or interim report), board changes, or capital updates. It is not a presentation deck or data supplement. It most closely fits our fallback “General Regulatory Filings” category for miscellaneous corporate announcements (RNS).
2026-04-14 English
Hofseth BioCare ASA: HBC ANNUAL REPORT 2025 - Attachment: hofsethbiocareasa-2025-12-31-1-en.zip
Annual Report (ESEF) Classification · 1% confidence FY 2025
2026-03-27 English
Hofseth BioCare ASA: HBC ANNUAL REPORT 2025 - Attachment: Hofseth Biocare 2025 ESG report.pdf
Environmental & Social Information Classification · 1% confidence The document is a standalone ESG report titled “ESG REPORT 2025” covering Governance, Environment, and Social topics. It follows GRI standards and focuses on the company’s sustainability performance, GHG emissions, resource use, social commitments, and governance structures. This matches the Environmental & Social Information category.
2026-03-27 English
Hofseth BioCare ASA: HBC ANNUAL REPORT 2025 - Attachment: Hofseth Biocare 2025 Annual report.pdf
Annual Report
2026-03-27 Norwegian
Hofseth BioCare ASA: HBC ANNUAL REPORT 2025
Report Publication Announcement Classification · 1% confidence The document is a short announcement (3,285 characters) stating that Hofseth BioCare ASA has published its Annual Report and Sustainability (ESG) Report for 2025 and that the reports are attached. There is no detailed financial data or full report content—only a notice of publication. Under the “menu vs meal” rule, this is a Report Publication Announcement (RPA).
2026-03-27 English
Hofseth BioCare ASA: Cancellation of Subsequent Offering - Update on completion of Private Placement
Capital/Financing Update Classification · 1% confidence The document is an official announcement from Hofseth BioCare ASA regarding the cancellation of a 'Subsequent Offering' and provides an update on the status of a 'Private Placement'. It details the board's decision to cancel the offering, the refund process for subscribers, and the reasons for the delay in the private placement. This falls under capital structure and financing activities, specifically the cancellation of a share offering, which aligns with the 'CAP' (Capital/Financing Update) category.
2025-12-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.